All In Biotech

Drug Trial Radar · NCT01211145

Zomig - Treatment of Acute Migraine Headache in Adolescents

A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents

Last checked: Nov 20, 2026Latest source record: May 18, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,653 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,653

Actual

Start

Sep 2010

Primary completion

Oct 2013

Study completion Oct 2013

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Sep 29, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate if Zomig® Nasal Spray will help children (age 12-17 years) with migraine headaches feel better. This will be done by comparing 3 different doses of Zomig Nasal Spray with placebo nasal spray (inactive treatment).

Conditions

  • Migraine Headache

Interventions

  • PlaceboDrug

    Placebo nasal spray

  • ZolmitriptanDrug

    0.5 mg nasal spray

  • ZolmitriptanDrug

    2.5 mg nasal spray

  • ZolmitriptanDrug

    5.0 mg nasal spray

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain-free Status at 2 Hours Post-treatmentTime frame: 2 hours post-treatment.

Locations

74 sites in 8 countries. Site status is shown where the registry gives one.

  • Research Site

    Phoenix, Arizona

  • Research Site

    Fresno, California

  • Research Site

    Fullerton, California

  • Research Site

    Newport Beach, California

  • Research Site

    Sacramento, California

  • Research Site

    San Diego, California

  • Research Site

    San Francisco, California

  • Research Site

    Centennial, Colorado

  • Research Site

    Colorado Springs, Colorado

  • Research Site

    Thornton, Colorado

  • Research Site

    Fairfield, Connecticut

  • Research Site

    Boca Raton, Florida

  • Research Site

    Hallandale, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Miami Lakes, Florida

  • Research Site

    North Palm Beach, Florida

  • Research Site

    Orlando, Florida

  • Research Site

    Tampa, Florida

  • Research Site

    West Palm Beach, Florida

  • Research Site

    Owensboro, Kentucky

  • Research Site

    Worcester, Massachusetts

  • Research Site

    Ann Arbor, Michigan

  • Research Site

    Plymouth, Minnesota

  • Research Site

    Ocean Springs, Mississippi

  • Research Site

    Olive Branch, Mississippi

  • Research Site

    Columbia, Missouri

  • Research Site

    Springfield, Missouri

  • Research Site

    St Louis, Missouri

  • Research Site

    The Bronx, New York

  • Research Site

    Cary, North Carolina

  • Research Site

    Hickory, North Carolina

  • Research Site

    Raleigh, North Carolina

  • Research Site

    Akron, Ohio

  • Research Site

    Cleveland, Ohio

  • Research Site

    Toledo, Ohio

  • Research Site

    Oklahoma City, Oklahoma

  • Research Site

    Indiana, Pennsylvania

  • Research Site

    Jackson, Tennessee

  • Research Site

    Nashville, Tennessee

  • Research Site

    San Antonio, Texas

Showing 40 of 74 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.